The funds will be used to expand operations and attract new partners.

The company received an additional equity investment from OrbiMed.

According to Dr. R. Ryan Sadeghian, healthcare AI thrives best on small, steady successes in areas like ambient documentation where clinician trust and workflow fit matter more than having the latest model.

About 300 million prescription records were used to train the AI to reveal drug safety issues and opportunities for repurposing medicines.

The company offers computer vision technology that enables humanoids and robots to perceive the world in 3D similar to how humans use their eyes and depth perception.

The company will use the funds to expand its technology and operations across Medicaid, Medicare Advantage and ACA marketplace plans in the U.S.